Dosage form for coadministering drug and percutaneous...

A - Human Necessities – 61 – M

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

128/104, 167/159

A61M 37/00 (2006.01) A61K 9/70 (2006.01)

Patent

CA 1166961

ARC 742 DOSAGE FORM FOR COADMINISTERING DRUG AND PERCUTANEOUS ABSORPTION ENHANCER Abstract A dosage form that coadministers a drug and a percutaneous absorption enhancer to a defined area of the skin. The dosage form comprises a body that contains supplies of drug and enhancer and has a basal surface that contacts the area of skin and transmits the drug and enhancer to the area for absorption thereby. The drug is provided to the basal surface at a rate at least as great as the rate at which the skin is able to absorb the drug whereas the enhancer is via a rate controlling means at a substantially constant rate that increases the permeability of the treated area of skin to the drug to a level at which the drug is absorbed at a therapeutically effective rate. A preferred embodiment delivers estradiol and employs ethanol as an enhancer, the ethanol delivery rate being about 100-800 mcg/hr/cm2 of skin surface. 4:0130:3P1CMG 12/18/81

395641

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Dosage form for coadministering drug and percutaneous... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dosage form for coadministering drug and percutaneous..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dosage form for coadministering drug and percutaneous... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1235313

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.